Google DeepMind has launched a new bioresilience program aimed at helping governments, researchers and biosecurity organizations detect and respond to biological threats as concerns over the intersection of advanced artificial intelligence and biotechnology continue to gain attention.
The initiative, announced Thursday, brings together Google DeepMind and drug discovery company Isomorphic Labs to support efforts in pathogen surveillance, vaccine and therapeutic design and outbreak response. The company said it has established more than 15 partnerships with governments, researchers and biosecurity groups over the past year.
